Exact Sciences to participate in September investor conference

Rhea-AI Summary

Exact Sciences Corp. to participate in Baird Global Healthcare Conference on September 12, 2023.

MADISON, Wis., Sept. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

• Baird Global Healthcare Conference, New York
  Fireside chat on Tuesday, September 12, 2023 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact: 
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-september-investor-conference-301915470.html

SOURCE Exact Sciences Corporation